Literature DB >> 14526446

The lymphoblastoid cell lines of recurrence condyloma acuminatum patients produce lower level of tumor necrosis factor stimulated with LPS.

Dongxian Liu1, Liyi Zhou, Xingping Chen.   

Abstract

To study the mechanism of Condyloma acuminatum (CA) recurrence, and the association of CA recurrence with the ability of the host derived lymphoblastoid cell lines (LCL) stimulated by LPS to produce tumor necrosis factor (TNF), EBV-transformed B LCL were used as TNF producing cells. The ability of LCL stimulated by LPS to produce TNF was measured by bioassay. The results showed that the LCL from CA patients (including recurrent and non-recurrent CA patients) produced similar level of TNF stimulated by LPS to that of normal controls (29.54% +/- 11.28% vs 34.31% +/- 11.46%, P = 0.1498). The LCL of CA recurrent patients produced significantly lower amount of TNF than that of non-recurrent CA patients (23.72% +/- 7.41% vs 37.33% +/- 11.10%, P = 0.0032). Compared with the normal controls, CA recurrent patients showed a decreased ability to produce TNF (23.72% +/- 7.41 vs 34.31% +/- 11.46, P = 0.0054), whereas CA non recurrent patients had the similar ability to the controls (37.33% +/- 11.10 vs 34.31% +/- 11.46, P = 0.4914). It was concluded that the onset of CA was not relevant to the individual's ability to produce TNF. But the recurrence of CA was associated with the ability to produce TNF. It was also indicated that the TNF involved cellular immunity might play an important role in the clearance of the residual HPV by the host after treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14526446     DOI: 10.1007/bf02829526

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  7 in total

Review 1.  Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions.

Authors:  J Vilcek; T H Lee
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

2.  Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus.

Authors:  C O Jacob; Z Fronek; G D Lewis; M Koo; J A Hansen; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

3.  Suppression of interleukin-2 production and activity by factor(s) released by peripheral blood mononuclear cells during papillomavirus infections.

Authors:  V Chopra; S K Tyring
Journal:  Viral Immunol       Date:  1991       Impact factor: 2.257

4.  Detection of tumour necrosis factor from lipopolysaccharide-stimulated human mononuclear cells by enzyme-linked immunosorbent assay and cytotoxicity bioassay.

Authors:  A Fomsgaard; H Worsaae; K Bendtzen
Journal:  Scand J Immunol       Date:  1988-02       Impact factor: 3.487

5.  The role of the immune system in anogenital human papillomavirus.

Authors:  I H Frazer
Journal:  Australas J Dermatol       Date:  1998-11       Impact factor: 2.875

6.  Molecular cloning of the complementary DNA for human tumor necrosis factor.

Authors:  A M Wang; A A Creasey; M B Ladner; L S Lin; J Strickler; J N Van Arsdell; R Yamamoto; D F Mark
Journal:  Science       Date:  1985-04-12       Impact factor: 47.728

7.  Production of tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta) by murine pre-B and B cell lymphomas.

Authors:  R Laskov; G Lancz; N H Ruddle; K M McGrath; S Specter; T Klein; J Y Djeu; H Friedman
Journal:  J Immunol       Date:  1990-05-01       Impact factor: 5.422

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.